“The brain-specific Ras/Rap-GTPase activating protein (Syn

“The brain-specific Ras/Rap-GTPase activating protein (SynGAP) is a prime candidate linking N-methyl-d-aspartate receptors to the regulation of the ERK/MAP kinase signalling cascade, suggested to be essential for experience-dependent synaptic plasticity. Here, we evaluated the behavioural phenotype of SynGAP heterozygous knockout mice (SG+/−), expressing roughly half the normal levels of SynGAP. In the cognitive domain, SG+/− mice demonstrated severe working and reference memory deficits in the radial arm maze task, a mild impairment early in the transfer

test of the water maze task, and a deficiency in spontaneous alternation in an elevated T-maze. In the non-cognitive domain, SG+/− mice were hyperactive in the open field and appeared less anxious in the elevated plus maze test. In contrast, object recognition mTOR inhibitor memory performance was not impaired in SG+/− mice. The reduction in SynGAP thus resulted in multiple behavioural traits suggestive of aberrant cognitive and non-cognitive processes

Daporinad manufacturer normally mediated by the hippocampus. Immunohistochemical evaluation further revealed a significant reduction in calbindin-positive interneurons in the hippocampus and doublecortin-positive neurons in the dentate gyrus of adult SG+/− mice. Heterozygous constitutive deletion of SynGAP is therefore associated with notable behavioural as well as morphological phenotypes indicative of hippocampal dysfunction. Any suggestion of a possible causal link between them however remains a matter for further investigation. “
“Certain bipolar cells in most species immunostain for GABA or its synthesizing enzyme glutamic acid decarboxylase. However, it is unknown whether they actually release GABA and, if so, from which cellular compartment and by what release mechanism. We investigated these questions in monkey retina where rod bipolar cells immunostain for GABA. We found that rod bipolar cells immunostain for one isoform of GAD (GAD65) in their somas, dendrites and axon terminals. Near the fovea, the somatic Acesulfame Potassium stain of rod bipolar cells is

weaker than that of horizontal cells but, at the periphery, it is stronger. Staining for the vesicular GABA transporter in monkey rod bipolar cells is negative. However, staining for the GABA transporter GAT3 is positive in the soma and primary dendrites (but not in the axon terminals). Staining for GAT3 is also positive in horizontal cells. Double staining of rod bipolar cells and the alpha subunit of the GABAA receptor reveals scarce GABAA puncta that appose rod bipolar dendrites. We conclude that monkey rod bipolar cells use GABA and discuss the possibility that they tonically release GABA from their dendrites using a reverse action of GAT3. “
“Presynaptic Ca2+ influx pathways, cytoplasmic Ca2+ buffering proteins and Ca2+ extrusion processes undergo considerable change during the first postnatal month in rodent neurons.

On the return flight to the United States, the girl was very thir

On the return flight to the United States, the girl was very thirsty and drank a large amount of liquid without subsequently urinating either on the plane or in the terminal upon landing. While Carfilzomib on a layover at Dulles International Airport (Dulles, VA), she became unresponsive. She was pronounced dead at a hospital an hour later. Her body was transferred to the Virginia Department of Health Office of the Chief Medical Examiner to perform an autopsy, as required by Virginia law in cases of

sudden unexpected death. On autopsy, she was normally developed and nourished but appeared ill and dehydrated. She had scabbed lesions on the left side of her face and left calf that were consistent with mosquito bites. The internal examination was nonspecific with congestion and edema in various organs and generalized lymphadenopathy. There was no significant trauma, congenital anomaly,

or discrete source of infection to cause her death. Elevated urea nitrogen and creatinine consistent with kidney failure were detected in vitreous sample. Tissues, including brain, heart, liver, and kidney, were submitted to CDC for consultation. Histopathology revealed characteristic intra-erythrocyte parasites suggestive of Plasmodium species. Immunohistochemistry Regorafenib research buy and polymerase chain reaction assays of autopsy tissues and serum confirmed infection with Plasmodium falciparum. Fatal malaria in this child who did not receive chemoprophylaxis or adequate diagnosis and treatment again illustrates the danger of acquiring malaria during travel. Because of the patient’s sudden death outside a health care facility, an autopsy was performed and a true cause of death was established. However, other travelers returning from abroad who become ill or expire may be examined without regard

to travel status.[5] Death may occur after a latency period,[6] Ketotifen and travel status may not be considered as a part of the cause of death. This might be especially true if the patient was found dead or was too ill to provide details on recent travel. There may be other cases where a true cause of death cannot be established because a postmortem examination was not performed. To better inform travelers and the clinicians who provide medical advice to persons before and after travel, it is important to understand factors associated with travel-associated severe illness. Surveillance systems cannot acquire the needed information to better learn from and prevent severe travel-associated illness if the illness is not identified or reported, and illness in patients who die before diagnosis might represent an important gap in our knowledge of these illnesses. GeoSentinel, a worldwide travel-related illness surveillance system, is one of the largest sources of information about illnesses acquired by travelers. GeoSentinel data reported by Freedman and colleagues identified fewer than 20 deaths between 1996 and 2004.

Finally, in the HAART periods we found an association between the

Finally, in the HAART periods we found an association between the increase in CD4 count and increases in the frequencies of GERD and HP infection, particularly for CD4 counts ≥200 cells/μL. This observation suggests that, whatever the effect of HAART, it is the improvement in immunity it produces that is associated with increased frequencies of see more HP infection and GERD. In conclusion, we observed a correlation between the improvement of immunity produced by HAART and the dramatic decrease in the frequency of

opportunistic complications. However, in the HAART era, candida oesophagitis was still prevalent, and increased rates of HP infection and GERD were found. Further trials may provide a better understanding of Selleck Dorsomorphin the mechanisms involved. We thank R. Saïdi, RN, for data collection, M. Delforge for statistical analysis, and Dr L. Watkins-Masters, MD, for valuable discussions. “
“Among people living with HIV, the proportion

of deaths attributed to chronic noninfectious comorbid diseases has increased over the past 15 years. This is partly a result of increased longevity in the era of highly active antiretroviral therapy (HAART), and also because HIV infection is related, causally or otherwise, to several chronic conditions. These comorbidities include conditions that are strongly associated with modifiable risk factors, such as cardiovascular disease (CVD), diabetes, and renal and bone diseases, and increasingly management guidelines for HIV recommend risk evaluation for these conditions. The uptake of these screening approaches is often limited by the resources required for their application, and hence the management of risk reduction in most HIV-infected populations falls below a reasonable standard. The situation is compounded by the fact that few risk calculators have been adjusted ZD1839 cost for specific use in HIV infection.

There is substantial overlap of risk factors for the four common comorbid diseases listed above that are especially relevant in HIV infection, and this offers an opportunity to develop a simple screening approach that encompasses the key risk factors for lifestyle-related chronic disease in people with HIV infection. This would identify those patients who require more in-depth investigation, and facilitate a stepwise approach to targeted management. Such a tool could improve communication between patient and clinician. A significant proportion of people with HIV are sufficiently engaged with their care to participate in health promotion and take the lead in using patient-centric screening measures. Health-based social networking offers a mechanism for dissemination of such a tool and is able to embed educational messages and support within the process.

No data are available on the concentration of ZDV in the oral cav

No data are available on the concentration of ZDV in the oral cavity. However, we expect that in the oral cavity the concentration of

the drug should be close to or lower than its Cmax (2 μg/mL). This assumption and previous data from studies investigating the effects of protease inhibitors on gingival tissues led us to use the concentrations indicated. The growth of the gingival epithelium was inhibited when the drug ZDV, an NRTI, was added at day 0 and was present throughout the growth period. In the present study, ZDV, even at lower concentrations (0.5 and 1 μg/mL), below the Cmax, affected the growth of the gingival epithelium, disrupting its proliferation and stratification status. These results support previous findings that indicated that the use of antiretroviral drugs resulted in the development of oral complications, especially with long-term use [2, 3, 5, 7, 9]. Our observations Epigenetic inhibitor concentration suggest that the oral epithelium in HIV-positive patients exposed to HAART, including ZDV, experiences drug-induced abnormalities

in the molecular and cellular biology of the tissue, which give rise to these oral complications. Epithelial tissues express different pairs of cytokeratin proteins depending on PFT�� research buy the epithelial cell type and stage of differentiation [17, 18]. During the process of terminal differentiation, keratinocytes lose their ability to proliferate and migrate from the basal layer to the superficial layers while BCKDHB undergoing a coordinated series of morphological, biochemical and genetic changes. The terminal differentiated

cell is a flattened dead cell that consists of a network of cytokeratin filaments surrounded by an insoluble envelope of heavily cross-linked protein [37]. When cells make the commitment to terminally differentiate, one of the changes to occur is a switch in cytokeratin gene expression. Expression of cytokeratins 5 and 14 is shut off and that of cytokeratin 1 and 10 is turned on [38]. Cytokeratin 10 is indicative of terminal differentiation and is expressed in the suprabasal layer of keratinized epithelia. It has also been reported that cytokeratin 10 protects the epithelium from trauma and damage [31]. To examine the effect of ZDV on the proliferation and differentiation of oral keratinocytes, we treated raft cultures at day 0 and at day 8. Normally, gingival stratified epithelia express the cytokeratin pair of cytokeratins 5 and 14 only in the proliferative basal layer; however, the cytokeratin pair is maintained in all layers of tissue [28, 30]. In this study, cytokeratins 5 and 14 were detected in all layers of the tissue in untreated samples. Application of ZDV decreased the amount of cytokeratin 5 present in tissues (Fig. 3). The amount of cytokeratin 14 present in tissues was also reduced (data not shown).

, 2007) Furthermore, fungi with no known sexual stage still have

, 2007). Furthermore, fungi with no known sexual stage still have functional MAT genes (Sharon et al., 1996; Kerényi et al., 2004), indicating that the lack of sexual reproduction in mitotic holomorphic species is caused by adverse mutations at loci other than the MAT locus. The reasons for the occurrence of functional MAT genes in fungi with no known sexual stage are not well understood. One plausible hypothesis is that the MAT transcriptional factors have some functions during the asexual Selleck Ipilimumab part of the life cycle and may regulate additional genes not involved directly

in sexual events (Hornok et al., 2007). The MAT genes may thus have a selective impact (e.g. through the stimulation of carotenoid production) on asexually reproducing populations. Another explanation is that these fungi have a cryptic sexual stage, but their teleomorphs have not been identified due to the extreme rarity of mating (Leslie & Klein, 1996; Turgeon, 1998). The regulatory mechanism(s) for light-inducible carotenogenesis in Fusarium species are not fully understood. The white collar (WC) proteins are regarded as a universal photoreceptor system regulating

carotenogenesis and other photoregulated processes in fungi (Corrochano & Avalos, 2010). Recent results on WC1-defective mutants in Fusarium oxysporum and F. fujikuroi indicate, however, that carotenogenesis is regulated differentially in members of the genus Fusarium (Avalos & Estrada, 2010). Light-inducible carotenogenesis selleck chemicals was retained in WC1 mutants of these Fusarium species, suggesting the existence of WC-independent photoreceptor mechanisms and/or the involvement of unknown factors in light-dependent carotenogenesis. Our present results confirm that F. verticillioides, like F. fujikuroi, has transcriptional control of carotenogenesis in response to light. The induction of car gene expression

and carotenoid biosynthesis are drastically reduced in the absence of a functional MAT1-2-1 gene. Thus, the regulation of light-induced carotenogenesis in F. verticillioides depends at least in part on MAT1-2-1. This gene is absent in the wild strain of N-acetylglucosamine-1-phosphate transferase the opposite sex, FGSC 7600, which, however, exhibits a normal light induction of carotenogenesis. Presumably, the regulatory role played by MAT1-2-1 in FGSC 7603 is played in FGSC 7600 by an equivalent MAT1-1 gene from its MAT locus (Yun et al., 2000). The available information on photoinduction of carotenogenesis in Fusarium suggests that it is a transcriptionally controlled mechanism mediated by a still unknown regulatory system. The attenuation of this photoresponse in the ΔFvMAT1-2-1 mutants of F. verticillioides reveals a novel key regulatory element in the carotenoid pathway whose connection with the light-inducing mechanism remains to be identified.

The analysis of the sensitivity measure d’ (shock

vs unp

The analysis of the sensitivity measure d’ (shock

vs. unpaired, −0.085 ± 0.72; right vs. left hand, −0.112 ± 0.78) showed that subjects performed at chance level in this task (shock vs. unpaired, t32 = −0.672, P = 0.506; right vs. left hand, t32 = −0.821, P = 0.417). In the pair comparison task, which was supposed to measure contingency awareness on a more implicit level, participants showed a similar performance. Their responses did not differ significantly from guessing rate when asked to identify the tone they found more pleasant in a pair of CS+ and CS− (mean percentage of correct identification of the CS−, 51.06 ± 11.75%; t32 = 0.519, P = 0.608). In the third task, we used affective priming to assess effects of automatic valence activation by the presentation of shock-conditioned or unpaired tones (primes) on response latencies in an evaluative decision task which required selleckchem the categorisation of subsequently presented adjectives (targets) according to their emotional meaning (positive or negative). The repeated-measures anova on the inverted RTs revealed a significant

main effect of Congruency (F1,32 = 8.159, P = 0.007). However, in contrast to our Idelalisib concentration hypothesis, congruent priming (inverted RTs, 0.930 1/sec ± 0.11) resulted in significantly slower RTs (i.e. smaller inverted RTs) than did incongruent priming (inverted RTs, 0.944 1/sec ± 0.11). Neither the main effect of Valence (F1,32 = 1.276, P = 0.267) nor the interaction of the two factors (F1,32 = 0.165, P = 0.687) was significant. The use of inverted and not log-transformed reaction times was based on visual inspection of the histograms that suggested a slightly better approximation to the normal distribution for the inverted than

for the log-transformed data. The results for the log-transformed data, however, were qualitatively the same (significant main effect of Congruency, F1,32 = 6.595; P = 0.015, no main effect of Valence, no interaction of Congruency and Valence). In the present study, we asked how emotionally salient auditory stimuli are processed in the human brain. More specifically, BCKDHA we investigated the spatiotemporal dynamics of auditory emotion processing after cross-modal aversive MultiCS conditioning with time-sensitive whole-head MEG. Consistent with our hypotheses, we obtained evidence for highly resolving differential processing of multiple shock-conditioned tones on initial cortical processing stages under challenging perceptual conditions and after a brief learning history. CS-evoked magnetic fields compared before and after conditioning were affect-specifically modulated in the time-range of the auditory N1m component between 100 and 150 ms after stimulus onset. Inverse source modelling within this time-interval revealed differential neural activity within a distributed network of left parietotemporal and right prefrontal cortex.

In the

same way, mice receiving 104 or 102 CFU were eutha

In the

same way, mice receiving 104 or 102 CFU were euthanized at days 3/4 or 5 postinfection, respectively. Bacterial inocula were prepared find more growing tagged strains overnight in LB at 28 °C. Cultures were centrifuged, diluted in physiological saline and inoculated to mice. Viable bacteria in the inocula were quantified by dilution and plating onto LB agar plates with appropriate antibiotics. MLN were removed daily postintraperitoneal infection and incubated for 20 min in 3 mL of HBSS containing 100 mg mL−1 of gentamicin, followed by three washes in 10 mL of HBSS without antibiotic, before single-cell suspensions were prepared using an iron mesh sieve. Then, the isolated cells were processed as described above (Expression and secretion of SopB in infected eukaryotic cells) in order to obtain a soluble and an insoluble fraction to analyze the expression and translocation, respectively. The expression and secretion of SopB was studied in vitro and in vivo using a FLAG-tagged strain of Salmonella Typhimurium. First, we analyzed the phenotype of the tagged

strains in all models of infection used throughout the experiments. As shown in Table 1, no significant differences in virulence were found between parental and tagged strains. These results are in accord with those reported earlier (Giacomodonato et al., 2007, 2009) and confirm that epitope tagging does not impair the invasiveness, colonization capacity or virulence of Salmonella. Consequently, we used our FLAG-tagged strains of Salmonella as a tool to study the in vitro and Gefitinib in vivo in vivo expression and translocation of SopB. To investigate the capacity of the Salmonella-tagged strains to synthesize and secrete SopB, bacteria were grown under different conditions resembling early and late stages of Salmonella infection (as described in Materials and methods). Under conditions that mimic the intestinal environment Salmonella synthesized SopB (Fig. 1b, lane 1). Interestingly, this effector protein was also found associated

with bacteria cultured under ALOX15 conditions that resemble the early and late intracellular environment (Fig. 1b, lanes 2 and 3), whereas SopA expression was evident only under conditions that mimic the intestinal milieu (Fig. 1a, lane 1). On the other hand, although SopB expression was evident under all conditions tested, its secretion was observed only into media that mimic the intestinal environment (Fig. 1e, lane 1). As expected for a dual effector translocated by both TTSSs, SopD was synthesized and secreted at similar levels under all conditions analyzed (Fig. 1c, lanes 1–3 and Fig. 1f, lanes 1–3). Taken together these results suggest that SopB can be synthesized not only by Salmonella located in the intestinal environment but also by intracellular bacteria. To investigate to what extent SopB is induced intracellularly, confluent HEp-2 cells were infected with Salmonella-tagged strains.

The application of marine stinger prevention and treatment princi

The application of marine stinger prevention and treatment principles throughout the region may help reduce the incidence and severity of such stings. Meanwhile travelers and their medical advisors should be aware of the hazards of these stings GSK1120212 in vivo throughout the Asia-Pacific. Jellyfish are a common cause of marine injuries world-wide. Most cases are minor and without permanent sequelae. However, box jellyfish can cause major stings with fatalities or severe systemic symptoms.1–4 Unfortunately, despite the development of many interventions to reduce this type of injury

in Australia,5 little documentation exists concerning the contemporary hazard represented by jellyfish stings in coastal regions of tropical developing countries. In a previous paper,2 these authors drew attention to the presence, and associated morbidity and mortality, of potentially deadly jellyfish in the coastal waters of Thailand, including chirodropids (larger multi-tentacled box jellyfish similar to Australia’s GSK3235025 solubility dmso Chironex fleckeri) and carybdeids (smaller box jellyfish with one tentacle in each corner), similar but distinct from the Australian jellyfish

Carukia barnesi,6 some of which may be associated with the Irukandji, or Irukandji-like, syndrome—hereafter referred to as Irukandji jellyfish. With the proximity to Thailand, and in the region where chirodropids occur, including the Philippines, where some 20 to 50 sting deaths occur annually,7 a similar problem is highly likely to occur in Malaysia, although such cases have been minimally documented.7,8 The recent box jellyfish-related deaths of several international tourists in both Thailand and Malaysia2,9–12 have emphasized these risks from marine stings in coastal areas

of Southeast Asia. Unfortunately, it is very difficult to access detailed and timely reports enabling injury prevention recommendations to address these emerging health issues. One recent innovation click here to facilitate such access about the health status of travel destinations, for near real-time infectious and toxic disease surveillance, has been internet-based reporting. Entities such as ProMed (www.promedmail.org/) and HealthMap (www.healthmap.org/en/) provide a focal point for collection, presentation, and dissemination of geospatially sophisticated health data to optimize travel health outcomes. We therefore applied this model of internet-based health data aggregation, together with conventional methods, to increase knowledge of box jellyfish stings in Malaysia, a major tourist destination in the region. Most case histories and images were obtained through Divers Alert Network Asia-Pacific (DAN AP) reports received since November 2007 from victims or witnesses; internet discussions from jellyfish discussion sites; Google Alerts (using the term “jellyfish stings”); media sources (Thailand, Malaysia, and Singapore on-line newspapers); and email contacts.

The nutritional differences among the habitats where these parasi

The nutritional differences among the habitats where these parasites thrive lead to remarkable variations in their energy metabolism (Coustou et al., 2008; Tielens & van Hellemond, 2009). To survive, these pathogens depend on a complex network of low-molecular-mass oxidoreductases; the detoxification of reactive oxygen and nitrogen species is accomplished by a complex redox cascade which utilizes the reducing equivalents derived from trypanothione. The latter dithiol molecule is notably abundant in

these pathogens (in the mM range) and is maintained in its reduced form by trypanothione reductase, NADPH being the primary source of reducing power for these processes (for review see Irigoin et al., 2008; Krauth-Siegel see more & Comini, 2008). In these parasites, large amounts of NADPH are required for de novo synthesis of fatty acids (for review see Lee et al., 2007). These molecules are needed to build the glycosylphosphatidylinositol anchors which attach the KU-57788 mw large amounts of glycoconjugates that coat the surface of these parasites (Ferguson, 1997; Donelson, 2003). These pathogens have redundant pathways to maintain the required reducing power, and the pentose phosphate pathway is a potential target for drug design against trypanosomes

(Hanau et al., 2004; Igoillo-Esteve et al., 2007). Malic enzymes (MEs), putative isocitrate dehydrogenases and glutamate dehydrogenases are among the other NADP-linked enzymes that are good candidates to contribute to NADPH production. Early findings showed that T. cruzi contains two MEs, a cytosolic and a mitochondrial isoform. Although these enzymes have not been completely purified, the enriched fractions exhibited high affinities for NADP and the cytosolic isozyme were strongly activated by l-aspartate (Cannata

et al., 1979; Cazzulo et al., 1980). Similarly, in T. brucei two putative MEs are predicted to be functional; recent RNAi studies showed that at least one of these isozymes is essential for parasite survival (Coustou et al., 2008). However, none of the T. brucei MEs has been functionally characterized, although the activity of one isozyme was determined Cediranib (AZD2171) in procyclics (Opperdoes & Cottem, 1982). The results presented herein provide a comparative description of the biochemical properties of T. cruzi and T. brucei MEs. Although the MEs from both parasites exhibit the same subcellular localization, they differ in their kinetic properties and developmental expression patterns. Procyclic forms of T. brucei stock 427 were grown as described previously (Brun & Schonenberger, 1979). The bloodstream forms of T. brucei stock 427 were grown in male Wistar rats; trypanosomes were obtained by cardiac puncture and separated from blood constituents by DEAE-cellulose chromatography (Lanham & Godfrey, 1970). Trypanosoma cruzi (CL Brener clone) insect and mammalian stages were grown as previously described (Cazzulo et al., 1985; Franke de Cazzulo et al., 1994). Total DNA was isolated from T.

Int J Radiat Oncol Biol Phys 2006; 65: 842–850 51 Watkins E, Fin

Int J Radiat Oncol Biol Phys 2006; 65: 842–850. 51 Watkins E, Findlay P, Gelmann E et al. Enhanced mucosal reactions in AIDS patients receiving orophanryngeal irradiation. Int J Radiat Oncol Biol Phys 1987; 13: 1403–1408. 52 Sanfilippo NJ, Mitchell J, Grew D, DeLacure M. Toxicity of head-and-neck radiation therapy in human immunodeficiency virus-positive MEK inhibitor patients. Int J Radiat Oncol Biol Phys 2010; 77: 1375–1379. 53 Evans MD, Yassa M, Podgorsak EB et al. Surface applicators for high dose rate brachytherapy in AIDS-related Kaposi’s sarcoma. Int J Radiat Oncol Biol Phys 1997; 39: 769–774. 54 Guo W-X, Gill PS, Antakly T. Inhibition of AIDS-Kaposi’s sarcoma cell proliferation following retinoic acid

receptor activation. Cancer Research 1995; 55: 823–829. 55 Walmsley S, Northfelt DW, Melosky B et al. Treatment of AIDS-related cutaneous Kaposi’s sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group. J Acquir Immune Defic Syndr 1999; 22: 235–246. 56 Bodsworth

NJ, Bloch M, Bower M et al. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% this website in cutaneous AIDS-related Kaposi’s sarcoma. Am J Clin Dermatol 2001; 2: 77–87. 57 Duvic M, Friedman-Kien AE, Looney DJ et al. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials. Arch Dermatol 2000; 136: clonidine 1461–1469. 58 Aboulafia DM, Norris D, Henry D et al. 9-cis-Retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial. Arch Dermatol 2003; 139: 178–186. 59 Boudreaux AA, Smith LL, Cosby CD et al. Intralesional vinblastine for cutaneous Kaposi’s sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection. J Am Acad Dermatol 1993; 28: 61–65. 60 Moyle G, Youle M, Barton S. Intralesional vinblastine in

the treatment of oral Kaposi’s sarcoma. Br J Clin Pract 1993; 47: 79–80. 61 Ramirez-Amador V, Esquivel-Pedraza L, Lozada-Nur F et al. Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi’s sarcoma. A double blind, randomized clinical trial. Oral Oncol 2002; 38: 460–467. 62 Tappero JW, Berger TG, Kaplan LD et al. Cryotherapy for cutaneous Kaposi’s sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a phase II trial. J Acquir Immune Defic Syndr 1991; 4: 839–846. 63 Hebeda KM, Huizing MT, Brouwer PA et al. Photodynamic therapy in AIDS-related cutaneous Kaposi’s sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10: 61–70. 64 Bernstein ZP, Wilson BD, Oseroff AR et al. Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi’s sarcoma. AIDS 1999; 13: 1697–1704. 65 Koon HB, Fingleton B, Lee JY et al. Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma.